Advanced search
Publication Cover
Leukemia & Lymphoma Volume 60, 2019 - Issue 2
Submit an article Journal homepage
220
Views
12
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET/CT in adult Burkitt’s lymphoma: the role of Deauville and IHP criteria

Domenico Albanoa Nuclear Medicine, Spedali Civili Brescia, Brescia, Italy; Correspondence[email protected]
,
Giovanni Bosioa Nuclear Medicine, Spedali Civili Brescia, Brescia, Italy;
,
Alessandro Reb Division of Hematology, Spedali Civili, Brescia, Italy;
,
Chiara Paganib Division of Hematology, Spedali Civili, Brescia, Italy;
,
Raffaele Giubbinic Nuclear Medicine, University of Brescia and Spedali Civili Brescia, Brescia, Italy
&
Francesco Bertagnac Nuclear Medicine, University of Brescia and Spedali Civili Brescia, Brescia, Italy
Pages 326-333 | Received 02 Mar 2018, Accepted 21 May 2018, Published online: 03 Jul 2018

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Zizheng Xiao, Yiwen Mo, Wen Long, Ruping Li, Xinling Li, Yuan Wei, Wei Fan & Xu Zhang. (2021) Value of baseline and end of chemotherapy 18F-FDG PET/CT in pediatric patients with Burkitt lymphoma. Leukemia & Lymphoma 62:12, pages 2873-2881.
Read now
Domenico Albano, Angelica Mazzoletti, Vittorio Ruggero Zilioli, Cristina Muzi, Lara Crucitti, Alessandra Tucci, Chiara Pagani, Alessandro Re, Claudio Rossetti, Raffaele Giubbini & Francesco Bertagna. (2020) Clinical and prognostic role of interim 18F-FDG PET/CT in elderly Hodgkin lymphoma: a dual-center experience. Leukemia & Lymphoma 61:13, pages 3209-3216.
Read now

Articles from other publishers (10)

Vishnu Murthy, Andrei Gafita, Pan Thin, Kathleen Nguyen, Tristan Grogan, John Shen, Alexandra Drakaki, Matthew Rettig, Johannes Czernin & Jeremie Calais. (2023) Prognostic Value of End-of-Treatment PSMA PET/CT in Patients Treated with 177 Lu-PSMA Radioligand Therapy: A Retrospective, Single-Center Analysis . Journal of Nuclear Medicine 64:11, pages 1737-1743.
Crossref
Merissa N. Zeman, Esma A. Akin, Reid W. Merryman & Heather A. Jacene. (2023) Interim FDG-PET/CT for Response Assessment of Lymphoma. Seminars in Nuclear Medicine 53:3, pages 371-388.
Crossref
Polisetty Sireesha, V Nithya, Gavini Surya, DS Hemalatha, Tekchand Kalawat, VSiva Kumar & RRamya Priya. (2023) A rare finding of pancreatic involvement in a case of burkitt's lymphoma. Indian Journal of Nuclear Medicine 38:1, pages 59.
Crossref
Alberto Marín-Sánchez, Gonzalo Martínez-Fernández, Irene Gómez-Catalán, Mari Carmen Montoya-Morcillo, Jesús Lorenzo Algarra-Algarra, Ángela Ibañez-García, Francisco Hernández-Fernández & Juan Ramón Romero-Macías. (2021) Efficacy of chemotherapy protocols for hematological malignancies: H-CVAD versus GELA/BURKIMAB/PETHEMA LAL. Experimental Hematology 101-102, pages 49-57.
Crossref
Yi Wen Mo, Zi Zheng Xiao, Yuan Wei, Xin Ling Li, Xu Zhang & Wei Fan. (2021) The Clinical Accuracy and Risk Stratification in End of Therapy 18F-FDG PET/CT in Burkitt Lymphoma. Frontiers in Oncology 11.
Crossref
Domenico Albano, Francesco Bertagna, Francesco Dondi, Salvatore Annunziata, Luca Ceriani, Luca Giovanella, Raffaele Giubbini & Giorgio Treglia. (2021) The Role of 2-[18F]-FDG PET/CT in Detecting Richter Transformation in Chronic Lymphocytic Leukemia: A Systematic Review. Radiation 1:1, pages 65-76.
Crossref
Li Wang, Ping Dong, Weiming Hu & Bole Tian. (2020) 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the diagnosis and follow-up of primary hepatic diffuse large B-cell Lymphoma. Medicine 99:5, pages e18980.
Crossref
Kevin Kalisz, Francesco Alessandrino, Rose Beck, Daniel Smith, Elias Kikano, Nikhil H. Ramaiya & Sree Harsha Tirumani. (2019) An update on Burkitt lymphoma: a review of pathogenesis and multimodality imaging assessment of disease presentation, treatment response, and recurrence. Insights into Imaging 10:1.
Crossref
J.G. Peacock, C.T. Christensen & K.P. Banks. (2019) RESISTing the Need to Quantify: Putting Qualitative FDG-PET/CT Tumor Response Assessment Criteria into Daily Practice. American Journal of Neuroradiology.
Crossref
Domenico Albano, Giovanni Bosio, Chiara Pagani, Alessandro Re, Alessandra Tucci, Raffaele Giubbini & Francesco Bertagna. (2018) Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in Burkitt lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 46:1, pages 87-96.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.